Lectureships and Visiting Professorships - Jack A. Roth, M.D.

---

1. Surgery of lung cancer, Lung and Lymphoma Cancer Conference, Fred J. Woods Radiation Therapy Center, Tampa, FL, February, 1981.
2. Surgery of lymphoma, Lung and Lymphoma Cancer Conference, Fred J. Woods Radiation Therapy Center, Tampa, FL, February, 1981.
3. Aggressive resection of pulmonary metastases from sarcomas, Visiting Professor, Department of Surgery, University of North Carolina Medical School, Chapel Hill, NC, June, 1982.
4. Multimodality therapy of esophageal carcinoma, Visiting Professor, Department of Surgery, Loch Raven VA Hospital, Baltimore, MD, June, 1983.
5. Resection of pulmonary metastases, Visiting Professor, Cardiothoracic Surgery Service, Walter Reed Army Hospital, Washington, DC, June, 1984.
6. Canadian esophageal cancer study group, Universite de Montreal, Montreal, Quebec, Canada, September, 1984.
7. Conference Chairman and Lecturer, Third Annual Hilton Head General Surgery Conference, Hilton Head, SC, September, 1984.
8. Adjuvant therapy for epidermoid carcinoma of the esophagus, Thoracic Surgery Seminar Metropolitan Chapter, American College of Surgeons, Washington, DC, March, 1985.
9. Surgical treatment of metastases in man, Plenary Session, Southwest Oncology Group, Houston, TX, March, 1985.
10. Combined modalities for the treatment of epidermoid carcinoma of the esophagus, Visiting Professor Oncology Seminar Series, Johns Hopkins Oncology Center, Baltimore, MD, April, 1985.
11. Multimodality therapy of esophageal carcinoma, Visiting Professor, Department of Surgery, Loch Raven VA Hospital, Baltimore, MD, May, 1985
12. Combined modality therapy for cancer of the esophagus, Georgetown University Hospital, Department of Surgery, Washington, DC, November, 1985.
13. Surgery for metastatic pulmonary nodules, Thoracic Surgery Seminar, Metropolitan Chapter, American College of Surgeons, Washington, DC, March, 1986.
14. Oncogenes and tumor antigens, Hybritech Incorporated, Del Mar, CA, March, 1987.
15. Immunotoxin therapy of metastatic cancer, American Cancer Society Science Writers' Seminar, San Diego, CA, March, 1987.
16. Therapy of esophageal cancer, Educational Session, Gastrointestinal Cancer Consortium, Chicago, IL., April, 1987.
17. Tumor stasis factor, Triton Biosciences, Alameda, CA, March, 1988.
18. Multimodality therapy of esophageal cancer, Visiting Professor, Department of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, WI, April, 1988.
19. Surgical Resection of Pulmonary Metastases, Visiting Professor, Toronto General Hospital and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada, May 30 - June 3, 1988.
20. Multimodality therapy for esophageal cancer, surgery and survival for pulmonary metastasectomy, multimodality therapy for lung cancer, General Thoracic Surgery Course, University of Toronto, Toronto, Ontario, Canada, June, 1988.
21. Preoperative chemotherapy and radiation for stage III non-small cell lung cancer, Society of Thoracic Surgeons, New Orleans, LA, September, 1988.
22. Surgery for metastatic disease to the lungs and mediastinum: indications and approaches, Society of Thoracic Surgeons, New Orleans, LA, September, 1988.
23. Optimizing management of primary bone tumors: resection of pulmonary metastases, The University of Texas M. D. Anderson Cancer Center, Houston, TX, November, 1988.
24. The role of surgery in the management of pulmonary metastases, Department of Surgery, University of Cincinnati, Cincinnati, OH, April, 1989.
25. Training of thoracic surgical oncologists, Thoracic Surgery Residency Directors Meeting, Baltimore, MD, September, 1989.
26. Tumor stasis factor, Triton Biosciences, Alameda, CA, September, 1989.
27. Cancer update: lung cancer, American College of Occupational Medicine, Houston, TX, May, 1990.
28. New therapeutic approaches to lung cancer, University of California, San Diego School of Medicine, San Diego, CA, August, 1990.
29. What's new in surgical oncology, American College of Surgeons, San Francisco, CA, October, 1990.
30. Multidisciplinary management of esophageal cancer, Visiting Professor, Department of Surgery, UCLA School of Medicine-CHS, Los Angeles, CA, September,1991.
31. Molecular approaches to cancer therapy, Visiting Professor, Department of Surgery, UCLA School of Medicine-CHS, Los Angeles, CA, September,1991.
32. Molecular surgery for cancer, Society of Surgical Oncology, New York, NY, March, 1992.
33. Molecular strategies for the prevention and treatment of cancer, First Invited Scientific Plenary Lecturer., Radiation Therapy Oncology Group, New Orleans, LA, January, 1993.
34. Targeting cancer genes, First International Conference on Gene Therapy and Vaccines to Cancer, Washington, DC, January, 1994.
35. Recent studies in molecular biology of lung cancer, CME Program, University of CA, Los Angeles, December, 1992.
36. Molecular surgery for cancer, Distinguished Lecturer, Grand Rounds at the New Jersey Medical School in Newark, NY, October, 1993.
37. Targeting cancer genes, 1st International Conference on Gene Therapy and Vaccines for Cancer, OMNI Shoreham Hotel, Washington, DC, January, 1994.
38. Oncogenes - from lab to clinic, American Cancer Society, Florida Division, March, 1994.
39. Resection for N2/N3 lung cancer, 47th Annual Cancer Symposium of the Society of Surgical Oncology, Houston, TX, March, 1994.
40. Gene therapy of cancer, Visiting Professor, Royal Victoria Hospital, E.J. Tabah, in Surgical Oncology, Montreal, Quebec, Canada, March, 1994.
41. Advances in the treatment of lung cancer, Visiting Professor, Royal Victoria Hospital, E.J. Tabah, in Surgical Oncology, Montreal, Quebec, Canada, March, 1994.
42. Esophageal carcinoma, Visiting Professor, Royal Victoria Hospital, E.J. Tabah, in Surgical Oncology, Montreal, Quebec, Canada, March, 1994.
43. Gene replacement therapy for lung cancer, Rhone-Poulenc Rorer, Paris, France, April 3-7, 1994.
44. Gene replacement strategies for therapy and prevention of lung cancer, 85th Annual Meeting of the American Association of Cancer Research, San Francisco, CA, April, 1994.
45. Adjuvant chemotherapy for stage IIIa and a selected subset of stage iiib non-small cell lung cancer, American Society Clinical Oncology Annual Meeting, Dallas, TX, May, 1994.
46. Biology of non-small cell lung cancer: applications for prevention and therapy, Current Perspective in the Treatment of Non-small Cell Lung Cancer Symposium, Colorado Springs, CO, June, 1994.
47. Gene replacement strategies for therapy and prevention of lung cancer, 9th Aspen Cancer Conference Workshop: Mechanisms of Toxicity and Carcinogenesis, Aspen, CO, July, 1994.
48. Gene Therapy for lung cancer, National Heart, Lung, and Blood Institute Conference on Genetics and Gene Therapy for the Study of Pulmonary Diseases, Rockville, MD, September., 1994.
49. Gene replacement strategies for cancer prevention and therapy, Keynote Speaker. The University of Texas M. D. Anderson CCOP Annual Meeting, September, 1994.
50. Gene replacement strategies for therapy and prevention of lung cancer, 32nd Annual Congress of Japan Society of Cancer Therapy Meeting, Okayama, Japan, October, 1994.
51. Novel strategies - the lung cancer model, the Ernest Bruell Lectureship, The Cleveland Clinic Cancer Center Research Conference, Cleveland, OH, October, 1994.
52. New approaches to cancer treatment and prevention: the lung cancer model , Cleveland Clinic Foundation, Cleveland, OH, October, 1994.
53. Gene replacement for cancer, First Gencell Meeting, Collegeville, PA, April, 1995.
54. Adenovirus-mediated gene therapy for malignant mesothelioma: a comparison of immunodeficient and immunocompetent tumor models, Invited Discussant, American Surgical Association 115th Annual Meeting, Chicago, IL. April, 1995.
55. Gene replacement for cancer, University of Minnesota, School of Medicine, Department of Surgery, June, 1995.
56. Gene replacement for cancer, Tenth Aspen Cancer Conference, Aspen, CO, July, 1995.
57. Gene replacement for cancer, Sixth International Congress on Anti-Cancer Treatment, Paris, France, February, 1996.
58. Ki-ras and p53 as target for gene therapy, 22nd National Cancer Congress of the German Cancer Society, Berlin, Germany, February, 1996.
59. Jack Sadler Memorial Lecture. University of Colorado Health Sciences Center, Denver, CO, April, 1996.
60. Strategies for gene replacement in lung cancer, Visiting Professor, Grand Rounds, Memorial Sloan Kettering, New York, NY, October, 1996.
61. Approaches to gene replacement for cancer, Wittcoff Lecturer, Scottsdale, AZ, November, 1996.
62. Mayo Clinic Charles Moetel Lectureship, Invited Lecturer, Mayo Clinic, Rochester, MN, March, 1997.
63. Future clinical approaches in the management of NSCLC with gene therapy, Invited Lecturer, O' Reilly Hall, University College, Dublin, Ireland, August, 1997.
64. Gene replacement for lung cancer, Plenary Session, O'Reilly Hall, University College, Dublin, Ireland, August, 1997.
65. Molecular approaches for therapy of lung cancer, Invited Lecturer, New Horizons in Non-Small Cell Lung Cancer, Cleveland Clinic Cancer Center, Cleveland, OH, September, 1997.
66. Local and systemic strategies for gene replacement for cancer, Hamilton-Fairley Memorial Lecture, British Association for Cancer Research, November, 1997.
67. Molecular basis for therapy in non-small lung cancer, Invited speaker, Canadian Association of Medical Oncologists, Toronto, Canada, April, 1999.
68. Gene replacement for cancer: local, systemic, and adjuvant strategies, Invited speaker, The George Washington University Grand Rounds, Washington, D.C., July, 1999.
69. Gene replacement for cancer, Texas A & M University, 2000 Graduate Research Symposium, College Station, TX, March, 2000
70. Gene therapy for cancer: p53 and beyond, Invited speaker, University of Pennsylvania Health System, Philadelphia, PA, April, 2000.

Back to Top